Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shui‐Ling Qin"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15065-15078 (2023)
Abstract Background and Aims Extrahepatic recurrence (EHR) is one of the major reasons for the poor prognosis of hepatocellular carcinoma (HCC). The present study aimed to develop and assess the performance of predictive models by using a combination
Externí odkaz:
https://doaj.org/article/2073caa4bc724cc89f4404e731ae9b77
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractPurpose The purpose of this study was to estimate the clinical efficacy and identify the best beneficiaries of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in hepatocellular carcinoma (HCC).Patients and methods A
Externí odkaz:
https://doaj.org/article/e299cf7fe5424e118d986037b4750d4c
Autor:
Lu‐Nan Qi, Liang Ma, Fei‐Xiang Wu, Yuan‐Yuan Chen, Jing‐Xuan Xu, Yu‐Chong Peng, Zu‐Shun Chen, Wen‐Feng Gong, Cheng‐Lei Yang, Hao‐Wen Wei, Shui‐Ling Qin, Jin‐Jie Shang, Qiu‐Yan Wang, Hong‐Ping Yu, Tao Peng, Ying‐Wu Huang, Yong‐Chi Ling, Wei‐Zhong Tang, Bang‐De Xiang, Le‐Qun Li
Publikováno v:
Liver International. 42:2283-2298
The multiplicity of hepatocellular carcinoma (HCC) recurrence patterns is the most important determinant of patients' postsurgical survival. A systematic HCC recurrence classification is needed to help prevent and treat postoperative HCC recurrence i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d9f8fb76c5552f673d9a461ed4fc981
https://doi.org/10.1111/liv.15363
https://doi.org/10.1111/liv.15363